New eye drops aim to halt worsening vision in keratoconus

NCT ID NCT07388069

ENROLLING_BY_INVITATION Disease control Sponsor: TheiaNova Ltd. Source: ClinicalTrials.gov ↗

First seen Feb 04, 2026 · Last updated May 22, 2026 · Updated 30 times

Summary

This early study tests whether TN-001 eye drops are safe and can stop keratoconus from getting worse. About 20 adults with progressive keratoconus will use the drops twice daily for 3-6 weeks. Researchers will monitor side effects and measure changes in the cornea and vision.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KERATOCONUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ophthalmic Trials Australia

    Brisbane, Queensland, 4005, Australia

Conditions

Explore the condition pages connected to this study.